PubMed · 12062160
RECKing MMP function: implications for cancer development.
Abstract
Cancer is a multistage process requiring progressive genetic and epigenetic changes in neoplastic and responding stromal cells. Many alterations that occur during the process of malignant progression are regulated by the matrix metalloproteinase (MMP) family of extracellular proteases and their endogenous inhibitors. Recent work has identified a new cell-surface inhibitor of MMPs - RECK. RECK regulates MMP-induced pericellular signaling cascades during embryogenesis and tumorigenesis. Homozygous loss of RECK results in embryonic lethality and attenuated tumor development in adults - thus providing further support for an efficacious role for protease inhibitors as anticancer therapeutics.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Jin-Sae Rhee, Lisa M Coussens. 2002. RECKing MMP function: implications for cancer development.. https://doi.org/10.1016/s0962-8924(02)02280-8. https://pubmed.health/record/pubmed%3A12062160/recking-mmp-function-implications-for-cancer-development
Citations retain the original authors and DOI and include this site’s record URL. If this discovery service contributed to your research, you can also cite PubMed Health by Indiciae: BibTeX · RIS.